Research Output per year
Fingerprint Dive into the research topics where Hyuncheol Chung is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 28 Similar Profiles
Stomach Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
oxaliplatin
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Stomach
Medicine & Life Sciences
Survival
Medicine & Life Sciences
docetaxel
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1986 2019
3
Citations
(Scopus)
A multicenter phase II study of AMG 337 in patients with MET-amplified gastric/gastroesophageal junction/esophageal adenocarcinoma and other MET-amplified solid tumors
Van Cutsem, E., Karaszewska, B., Kang, Y. K., Chung, H., Shankaran, V., Siena, S., Go, N. F., Yang, H., Schupp, M. & Cunningham, D., 2019 Apr 15, In : Clinical Cancer Research. 25, 8, p. 2414-2423 10 p.Research output: Contribution to journal › Article
Esophagogastric Junction
Stomach
Adenocarcinoma
Neoplasms
Disease-Free Survival
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
Bang, Y. J., Kang, Y. K., Ng, M., Chung, H., Wainberg, Z. A., Gendreau, S., Chan, W. Y., Xu, N., Maslyar, D., Meng, R., Chau, I. & Ajani, J. A., 2019 Feb 1, In : European Journal of Cancer. 108, p. 17-24 8 p.Research output: Contribution to journal › Article
Esophagogastric Junction
Stomach
Disease-Free Survival
Placebos
Neoplasms
2
Citations
(Scopus)
Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: Phase 1b results from the JAVELIN Solid Tumor trial
Chung, H., Arkenau, H. T., Lee, J., Rha, S., Oh, D. Y., Wyrwicz, L., Kang, Y. K., Lee, K. W., Infante, J. R., Lee, S. S., Kemeny, M., Keilholz, U., Melichar, B., Mita, A., Plummer, R., Smith, D., Gelb, A. B., Xiong, H., Hong, J., Chand, V. & 1 others, , 2019 Feb 4, In : Journal for ImmunoTherapy of Cancer. 7, 1, 30.Research output: Contribution to journal › Article
Esophagogastric Junction
Stomach
Maintenance
Disease-Free Survival
Neoplasms
Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot study
Kim, Y. H., Kim, G. M., Son, S., Song, M., Park, S., Chung, H. & Lee, S. M., 2019 Jan 1, In : Supportive Care in Cancer.Research output: Contribution to journal › Article
Food Preferences
Breast Neoplasms
Drug Therapy
Taste Threshold
Malnutrition
1
Citation
(Scopus)
Differences in the efficacies of pazopanib and gemcitabine/docetaxel as second-line treatments for metastatic soft tissue sarcoma
Kim, J. H., Park, H. S., Heo, S. J., Kim, S. K., Han, J. W., Shin, K. H., Kim, S. H., Hur, H., Kim, K. S., Choi, Y., Kim, S., Lee, Y. H., Suh, J., Ahn, J. B., Chung, H., Noh, S. H., Rha, S. & Kim, H. S., 2019 Feb 1, In : Oncology (Switzerland). 96, 2, p. 59-69 11 p.Research output: Contribution to journal › Article
docetaxel
gemcitabine
Sarcoma
Therapeutics
Synovial Sarcoma